Meigs syndrome: Difference between revisions

Jump to navigation Jump to search
Line 38: Line 38:


==Epidemiology and Demographics==
==Epidemiology and Demographics==
==Prevalence==
* The prevalence of Meigs syndrome is unknown.<ref name="pmid22369402">{{cite journal |vauthors=Annaiah TK, Reynolds SF, Lopez C |title=Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? |journal=J Obstet Gynaecol |volume=32 |issue=3 |pages=267–70 |year=2012 |pmid=22369402 |doi=10.3109/01443615.2011.626089 |url=}}</ref>
* The prevalence of Meigs syndrome is unknown.<ref name="pmid22369402">{{cite journal |vauthors=Annaiah TK, Reynolds SF, Lopez C |title=Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? |journal=J Obstet Gynaecol |volume=32 |issue=3 |pages=267–70 |year=2012 |pmid=22369402 |doi=10.3109/01443615.2011.626089 |url=}}</ref>
*The prevalence of benign ovarian tumors is approximately 2-10%, and only 1-2% develop Meigs syndrome.<ref name="pmid22369402">{{cite journal |vauthors=Annaiah TK, Reynolds SF, Lopez C |title=Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? |journal=J Obstet Gynaecol |volume=32 |issue=3 |pages=267–70 |year=2012 |pmid=22369402 |doi=10.3109/01443615.2011.626089 |url=}}</ref>
*The prevalence of benign ovarian tumors is approximately 2-10%, and only 1-2% develop Meigs syndrome.<ref name="pmid22369402">{{cite journal |vauthors=Annaiah TK, Reynolds SF, Lopez C |title=Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? |journal=J Obstet Gynaecol |volume=32 |issue=3 |pages=267–70 |year=2012 |pmid=22369402 |doi=10.3109/01443615.2011.626089 |url=}}</ref>
Line 50: Line 51:
===Race===
===Race===
*There is no racial predilection for Meigs syndrome.
*There is no racial predilection for Meigs syndrome.
*Meigs syndrome usually affects individuals with higher socioeconomic status.  
*Meigs syndrome usually affects females with higher socioeconomic status.<ref name="pmid22369402">{{cite journal |vauthors=Annaiah TK, Reynolds SF, Lopez C |title=Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? |journal=J Obstet Gynaecol |volume=32 |issue=3 |pages=267–70 |year=2012 |pmid=22369402 |doi=10.3109/01443615.2011.626089 |url=}}</ref>
*[Race 2] individuals are less likely to develop Meigs syndrome.


==Risk Factors==
==Risk Factors==

Revision as of 13:43, 29 March 2016

WikiDoc Resources for Meigs syndrome

Articles

Most recent articles on Meigs syndrome

Most cited articles on Meigs syndrome

Review articles on Meigs syndrome

Articles on Meigs syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Meigs syndrome

Images of Meigs syndrome

Photos of Meigs syndrome

Podcasts & MP3s on Meigs syndrome

Videos on Meigs syndrome

Evidence Based Medicine

Cochrane Collaboration on Meigs syndrome

Bandolier on Meigs syndrome

TRIP on Meigs syndrome

Clinical Trials

Ongoing Trials on Meigs syndrome at Clinical Trials.gov

Trial results on Meigs syndrome

Clinical Trials on Meigs syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Meigs syndrome

NICE Guidance on Meigs syndrome

NHS PRODIGY Guidance

FDA on Meigs syndrome

CDC on Meigs syndrome

Books

Books on Meigs syndrome

News

Meigs syndrome in the news

Be alerted to news on Meigs syndrome

News trends on Meigs syndrome

Commentary

Blogs on Meigs syndrome

Definitions

Definitions of Meigs syndrome

Patient Resources / Community

Patient resources on Meigs syndrome

Discussion groups on Meigs syndrome

Patient Handouts on Meigs syndrome

Directions to Hospitals Treating Meigs syndrome

Risk calculators and risk factors for Meigs syndrome

Healthcare Provider Resources

Symptoms of Meigs syndrome

Causes & Risk Factors for Meigs syndrome

Diagnostic studies for Meigs syndrome

Treatment of Meigs syndrome

Continuing Medical Education (CME)

CME Programs on Meigs syndrome

International

Meigs syndrome en Espanol

Meigs syndrome en Francais

Business

Meigs syndrome in the Marketplace

Patents on Meigs syndrome

Experimental / Informatics

List of terms related to Meigs syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Demons Meigs syndrome; Meigs-Cass syndrome; Meigs-Salmon syndrome

Overview

Meigs syndrome (also known as "Demons Meigs syndrome") is defined as the triad of ascites, pleural effusion, and benign ovarian tumor (fibroma, Brenner tumour and occasionally granulosa cell tumour). Meigs syndrome was first discovered by Otto von Spiegelberg, a German gynecologist, in 1866.[1]

Historical Perspective

  • Meigs syndrome was first discovered by Otto von Spiegelberg, a German gynecologist, in 1866.[1]
  • Meigs syndrome is named after Joe Vincent Meigs, an American gynecologist who defined Meigs syndrome as the presence of ascites, hydrothorax, association with benign ovarian tumor.[2]
  • In 1900, the first therapeutical surgical approach was developed by Albert Jean Octave Demons to treat Meigs syndrome.[3]

Classification

  • There is no classification system established for Meigs syndrome.[4]
  • Other variants of Meigs syndrome include pseudo-meigs syndrome, and atypical Meigs' syndrome.

Pathophysiology

  • The pathogenesis of Meigs syndrome is characterized by a transudative process.
  • The transudative process consists in the formation of peritoneal and pleural effusion to the filtration of interstitial fluid in the peritoneum through the tumor capsule, and the diffusion to the pleural space.[5]
  • There are no genes associated with the development of Meigs syndrome.
  • On gross pathology, marked ovarian enlargement, watery cut surface,and no necrosis are characteristic findings of Meigs syndrome.
  • On microscopic histopathological analysis, variable stromal luteinization, marked edema of stroma surrounding follicles, and stroma around vessels are characteristic findings of Meigs syndrome.[6]

Causes

  • Meigs syndrome may be caused by either ovarian fibroma, Brenner tumor, or granulosa cell tumor.[7]
  • In general, Meigs syndrome may be caused by any benign ovarian tumor.

Differentiating Meigs syndrome from other Diseases

  • Meigs syndrome must be differentiated from other diseases that cause bloating, fatigue, and shortness of breath such as:[8]
  • Ovarian cancer
  • Cirrhosis
  • Colon cancer
  • Tuberculosis
  • Milroy's disease

Epidemiology and Demographics

Prevalence

  • The prevalence of Meigs syndrome is unknown.[9]
  • The prevalence of benign ovarian tumors is approximately 2-10%, and only 1-2% develop Meigs syndrome.[9]

Age

  • Meigs syndrome is more commonly observed among postmenopausal women.
  • The median age at diagnosis is approximately 50 years.

Gender

  • Meigs syndrome affects exclusively females.

Race

  • There is no racial predilection for Meigs syndrome.
  • Meigs syndrome usually affects females with higher socioeconomic status.[9]

Risk Factors

  • Common risk factors in the development of Meigs syndrome are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with Meigs syndrome remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with Meigs syndrome may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of Meigs syndrome include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with Meigs syndrome is approximately [#%].

Diagnosis

Diagnostic Criteria

  • The diagnosis of Meigs syndrome is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms

  • Meigs syndrome is usually asymptomatic.
  • Symptoms of Meigs syndrome may include the following:
  • [symptom 1]
  • [symptom 2]
  • [symptom 3]
  • [symptom 4]
  • [symptom 5]
  • [symptom 6]

Physical Examination

  • Patients with Meigs syndrome usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings

  • There are no specific laboratory findings associated with Meigs syndrome.
  • A [positive/negative] [test name] is diagnostic of Meigs syndrome.
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of Meigs syndrome.
  • Other laboratory findings consistent with the diagnosis of Meigs syndrome include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

  • There are no [imaging study] findings associated with Meigs syndrome.
  • [Imaging study 1] is the imaging modality of choice for Meigs syndrome.
  • On [imaging study 1], Meigs syndrome is characterized by [finding 1], [finding 2], and [finding 3].
  • [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

  • Meigs syndrome may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • There is no treatment for Meigs syndrome; the mainstay of therapy is supportive care.
  • The mainstay of therapy for Meigs syndrome is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for Meigs syndrome.
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of Meigs syndrome.
  • [Surgical procedure] can only be performed for patients with [disease stage] Meigs syndrome.

Prevention

  • There are no primary preventive measures available for Meigs syndrome.
  • Effective measures for the primary prevention of Meigs syndrome include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with Meigs syndrome are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References

  1. 1.0 1.1 Tait L (1892). "On the occurrence of Pleural Effusion in association with Disease of the Abdomen". Med Chir Trans. 75: 109–18. PMC 2036288. PMID 20896800.
  2. Lurie S (2000). "Meigs' syndrome: the history of the eponym". Eur. J. Obstet. Gynecol. Reprod. Biol. 92 (2): 199–204. PMID 10996681.
  3. MEIGS JV (1954). "Fibroma of the ovary with ascites and hydrothorax; Meigs' syndrome". Am. J. Obstet. Gynecol. 67 (5): 962–85. PMID 13148256.
  4. Gil A, Roque A, Alemán C (2015). "[Meigs' syndrome]". Med Clin (Barc) (in Spanish; Castilian). 145 (2): 95. doi:10.1016/j.medcli.2014.12.007. PMID 25662723.
  5. Santopaolo O, Rotondo A, Alfè M, Canciello P, Rito Marcone G, Cusati B (1993). "[Meigs syndrome with bilateral hydrothorax]". Minerva Ginecol (in Italian). 45 (5): 263–6. PMID 8351065.
  6. Ovary - nontumor. Pathology Outlines. http://www.pathologyoutlines.com/topic/ovarymassiveedema.html Accessed on March 29,2016
  7. Meigs syndrome. Wikipedia. https://en.wikipedia.org/wiki/Meigs'_syndrome Accessed on March 29, 2016
  8. Riker D, Goba D (2013). "Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome". J Bronchology Interv Pulmonol. 20 (1): 48–51. doi:10.1097/LBR.0b013e31827ccb35. PMID 23328144.
  9. 9.0 9.1 9.2 Annaiah TK, Reynolds SF, Lopez C (2012). "Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases?". J Obstet Gynaecol. 32 (3): 267–70. doi:10.3109/01443615.2011.626089. PMID 22369402.